trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Semaglutide (Ozempic) lowers blood pressure in adults with type 2 diabetes or obesity.

the verdict
INSUFFICIENT LEANING
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Semaglutide (Ozempic) lowers blood pressure in adults with type 2 diabetes or obesity?

Unclear. A 2024 meta-analysis of 29 RCTs in type 2 diabetes found semaglutide reduced systolic blood pressure by about 2.3 mmHg versus placebo or other agents, with no significant diastolic change. Several reviews and a small case series also note blood pressure improvements, but none provides a dedicated trial in obesity populations.

Verdict: PARTIAL LEAN · 4 sources for, 0 against · Last checked

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Evidence for · 4
The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis -
Get citation
The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.1007/s12020-023-03636-9

See more details
More for · 3
Ozempic (semaglutide) - review of pharmacological properties, mechanism of action and clinical applications
2024
Get citation
Ozempic (semaglutide) - review of pharmacological properties, mechanism of action and clinical applications. (2024). doi.org. https://doi.org/10.12775/qs.2024.16.52659

Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis
Get citation
Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis. (n.d.). cir.nii.ac.jp. https://doi.org/10.1159/000527919

EFFICACY AND SAFETY OF SEMAGLUTIDE FOR WEIGHT LOSS
2025
Get citation
Thaiz, S. & Bárbara, D. R. (2025). EFFICACY AND SAFETY OF SEMAGLUTIDE FOR WEIGHT LOSS. zenodo.org. https://doi.org/10.5281/zenodo.17815945

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work